Commonwealth Equity Services
MDCO

Commonwealth Equity Services’s Medicines Co MDCO Stock Holding History

Commonwealth Equity Services’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,250
Closed -$200K – 2637
2017
Q2 		$200K Hold
5,250
– – ﹤0.01% 2233
2017
Q1 		$257K Buy
+5,250
New +$239K ﹤0.01% 1971

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services's MDCO Position: Q3 2017 in Review

Commonwealth Equity Services sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 5,250 shares — an estimated $200K sold.

Commonwealth Equity Services first reported a position in MDCO in Q1 2017 and held it in 2 quarters. The position peaked at $257K in Q1 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • Commonwealth Equity Services reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • Commonwealth Equity Services sold 5,250 Medicines Co shares in Q3 2017, an estimated $200K.
  • Commonwealth Equity Services first reported a position in Medicines Co in Q1 2017 and held it in 2 quarters.
  • Commonwealth Equity Services's Medicines Co position peaked at $257K in Q1 2017.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Commonwealth Equity Services's 13F filing for Q3 2017, filed 7 Nov 2017.